Navigation Links
Nile Therapeutics to Present at the 27th Annual J.P. Morgan Healthcare Conference
Date:1/13/2009

SAN FRANCISCO, Jan. 13 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc., (Nasdaq: NLTX), announced today that Peter Strumph, Chief Executive Officer, will present at the 27th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th, at 4:30 p.m. PT in the California East Room at The Westin St. Francis Hotel in San Francisco, CA.

Mr. Strumph will provide an overview of Nile and its clinical development programs for its lead compound, CD-NP, a novel chimeric peptide for the treatment of acute heart failure.

About Nile Therapeutics

Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical need. Nile is initially focusing its efforts on developing its lead compound, CD-NP, a novel rationally designed chimeric peptide in clinical studies for the treatment of heart failure; 2NTX-99, a small molecule, pre-clinical, anti-atherothrombotic agent with nitric oxide donating properties; and CU-NP, a novel rationally designed natriuretic peptide. More information on Nile can be found at http://www.nilethera.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, outlook, milestones, the success of Nile's product development, future financial position, future financial results, plans and objectives of management are forward-looking statements. We may not actually achieve these plans, intentions or expectations and Nile cautions investors not to place undue reliance on
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
2. AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics
3. Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals
4. Orexigen(R) Therapeutics to Speak at J.P. Morgan Healthcare Conference
5. Prime Therapeutics Hires Steven Blumenfield as Chief Marketing Officer
6. Cell Therapeutics and Spectrum Pharmaceuticals Close Transaction Forming Joint Venture to Market Zevalin in the US
7. Pain Therapeutics Receives Complete Response Letter From FDA for REMOXY(R)
8. Prime Therapeutics Announces Blue Cross and Blue Shield of Montana as a Pharmacy Benefit Services Client
9. Agile Therapeutics Abstracts on Lead Product, AG200-15 Accepted by ACOG
10. Cell Therapeutics, Inc. to Offer to Repurchase up to $124 Million of Its Notes
11. Horizon Therapeutics announces 2 pivotal HZT-501 Phase 3 trials meet primary endpoints

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... Innovative medical apparel compa...nce , San Clemente, Calif...r of breakthrough medical apparel, today announced...isplay at Medica 2009, a leading international tra...f, Germany. Medelita inaugurates its men,s collect...
(Date:11/21/2009)... Eric J. Hall, president and chie...of America (AFA) issued the following statement re...ction as part of the new annual wellness for Medic...and Affordable Care Act" that was introduced ...Y (PRWEB) November 21, 2009 -- Eric J. Hall, presi...
(Date:11/21/2009)... Linwood Group ask whether there ...be measured? , London, UK... that with up to one in three of the adult UK popu... developing alcohol-related liver disease*, it is ...ng to rehabilitation programmes and residential ce...
(Date:11/20/2009)..., PRINCETON, NJ, Nov. 20 /PRNewswire-FirstCall/ ...at a Special Meeting of Shareholders will be held ...eeting is to consider approval of two special reso...e and authorize the sale of all or substantially a...terms provided for in the asset purchase agreement...
(Date:11/20/2009)... , WASHINGTON, Nov. 20 /PRNewswire-USNewswire...ops urged the Senate to make essential changes its...ral law on abortion funding and conscience protect... immigrants and include strong provisions for adeq...enate health care bill an "enormous disappointment...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2
...ermal ablation and radiation therapy, when used to...perable lung cancer, increases chances of surviv... In a retrospective study looking at patients ove...by radiation for treatment of non-small-cell lung ...
...ied due to suspected chikungunya in three district...spital sources said. // While four patients ...huser respectively, they said. Many others were be...d not chikungunya. The blood samples of the a...
...s Ltd today said Nihon Pharmaceutical Industry Ltd...sed Nippon Chemiphar Ltd // , has launched the ant...ine' tablets in the Japanese market. Clarit... million dollars respectively in Japan, for the ab...
...d insurance company has devised a chip that can be...of recording medical histories. This will assist//...nts' medical data. Horizon Blue Cross and B... The chip can be interpreted with the use of ...
... computers all over the world could help to tackle... the installation of a specialized software.// ...isation Européenne pour la Recherche Nucléaire - t...ter is turned on. When the software runs in ...
...(G8) leaders here Sunday set a series of guideline...dopting a document on the issue.// "A vigoro...the leading cause of death worldwide, is essential...nt emergence of highly pathogenic avian influenza ...
Other Medicine News:Health News:Combination Therapy to the Rescue off Lung Cancer Patients 2Health News:Combination Therapy to the Rescue off Lung Cancer Patients 3Health News:Africa Set to Control Malaria Using Specialized Software 2
(Date:11/19/2009)...et Week of Action ,, SILVER SPRING, Md., Nov. ...ug Administration today completed a coordinated, w...ional Internet Week of Action (IIWA), intended to ..., (Logo: http://www.newscom.com/cgi-bin/prnh/2...,s Office of Criminal Investigations (OCI), in con...
(Date:11/19/2009)...wswire/ -- Breast-Specific Gamma Imaging/Molecular... endorsed by two highly esteemed organizations for...reast Imaging (SBI) and the American College of Su...ng the further application of this breakthrough im... cancer. ,, "These endorsements reinforce what ...
(Date:11/19/2009)...net Week of Action ,, SILVER SPRING, Md., Nov....ug Administration today completed a coordinated, w...ional Internet Week of Action (IIWA), intended to ..., (Logo: http://www.newscom.com/cgi-bin/prnh/...DA,s Office of Criminal Investigations (OCI), in c...
Breaking Medicine Technology:UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3FDA Issues 22 Warning Letters to Web Site Operators 2SourceMedical 26apos 3Bs Therapy Software Partners with FOTO the Leading Provider of Patient Outcome Surveys 14463 1SourceMedical 26apos 3Bs Therapy Software Partners with FOTO the Leading Provider of Patient Outcome Surveys 14463 2SourceMedical 26apos 3Bs Therapy Software Partners with FOTO the Leading Provider of Patient Outcome Surveys 14463 3First Commercial Text Messaging Smoking Cessation Service Marks One Year of Operation 59427 1First Commercial Text Messaging Smoking Cessation Service Marks One Year of Operation 59427 2First Commercial Text Messaging Smoking Cessation Service Marks One Year of Operation 59427 3STEMCELL Technologies Inc Announces Release of Defined Animal Protein Free Maintenance Medium for hESCs and hiPSCs 59424 1STEMCELL Technologies Inc Announces Release of Defined Animal Protein Free Maintenance Medium for hESCs and hiPSCs 59424 2
...ly non-responders unlikely to subsequently,respond... benefit,from earlier change in treatment strategy...ire-FirstCall/,-- New data presented at the 2007 I...COSR) suggest that antipsychotic drug,response be ...allenge the current schizophrenia treatment paradi...
...ng of the European Association for the Study,of th...re/ -- Pharmasset,announced today that presentatio...atment of hepatitis B (HBV) and PSI-6130, the,pare...is C (HCV),will be made during the 42nd Annual Mee...the Liver (EASL) being held in,Barcelona, Spain fr...
Other Medicine Technology:New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 2New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 3New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 4New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 6Pharmasset Announces Clevudine and Hepatitis C Presentations at,EASL 2Pharmasset Announces Clevudine and Hepatitis C Presentations at,EASL 3Pharmasset Announces Clevudine and Hepatitis C Presentations at,EASL 4
Laser 3 mirror Contact Lens 906 L
... OM 900 Ophthalmometer uses a classical distance-i...ee requirements of Helmholtz: 1. The size of the m...he Ophthalmometer and the measured object; 2. The ...ance between the Ophthalmometer and the measured o...
...dows-based image capture and management system tha..., fluorescent and ICG Angiography images. It inter...o obtain images from any ophthalmic device with vi...igh quality colour Retinal Images from non-mydriat...
Non Contact Lens 81 D
Medicine Products: